FYI from the NHLBI Index
January 2010: Vol. 10, Issue 3
Summaries of Meetings
and Announcements of Upcoming Events
National Heart, Lung, and Blood Advisory Council's September and October Meetings
Upcoming NHLBI Workshops and Working Groups
Upcoming 2010 Events
National Heart, Lung, and Blood Advisory Council's September and October Meetings
September 1, 2009
Dr. Elizabeth Nabel, Director of the NHLBI, welcomed members to the 235th meeting of the National Heart,
Lung, and Blood Advisory Council (NHLBAC). The meeting was entirely a closed session. Council members attended via video
conference and telephone. The Council concurred on the award of numerous research grants to be supported with FY 2009
appropriated funds and American Recovery and Reinvestment Act (ARRA) funds.
October 20, 2009
Dr. Nabel welcomed members to the 236th meeting of the NHLBAC. She also welcomed representatives
of three NHLBI Advisory Committees: Dr. C. William Balke, representing the NHLBI Institutional Training Mechanism Review Committee;
Dr. Charles Czeisler, representing the Sleep Disorder Research Advisory Board; and Dr. John J. Reilly, Jr., representing the Clinical
Trials Review Committee. Dr. Nabel noted that Dr. Edward Benz of the Sickle Cell Disease Advisory Committee and Dr. Anne Marie Schmidt
of the National Heart, Lung, and Blood Program Project Review Committee were unable to attend.
Dr. Nabel recognized five Council members who are retiring: Dr. Victor Dzau, Dr. Helen Hobbs, Dr. Jennie Joe,
Dr. Joseph Loscalzo, and Dr. S. K. Rao Musunuru.
Dr. Nabel announced that the NIH is operating under a Continuing Resolution, which means that the NHLBI must operate
at its FY 2009 budget level of $3,014,552,000. She reviewed the Institute's proposed FY 2010 President's Budget, which totals
$3,050,356,000, a 1.3 percent increase over the FY 2009 actual budget. Total research project grants (noncompeting and competing)
are proposed at $2,051,848,000, a 0.6 percent increase over FY 2009. Dr. Nabel also reviewed the Institute's FY 2009/FY 2010 ARRA
funding plan. Most of the Institute's ARRA allotment has been obligated.
Dr. Nabel updated the Council on progress in implementing recommended actions resulting from the recent NIH-led
study of the NIH peer review system. Changes in 2009 include phasing out second amendments and implementing enhanced review
criteria, a new scoring system, and structured critiques.
Dr. Nabel also noted that investigators submitting competing applications for the January 25, 2010, submission
date (and beyond) should be aware of the restructured application forms, shorter page limits, and new instructions.
Dr. Nabel described the Institute’s participation in two new global health programs: the NHLBI Centers
of Excellence, a partnership between the NHLBI and UnitedHealth Group which will address non-communicable chronic cardiovascular
and pulmonary diseases in developing countries and the Global Alliance for Chronic Diseases, which is the first collaboration
of major international biomedical research funding agencies to address chronic noncommunicable diseases.
Dr. Toren Finkel, Chief of the Translational Medicine Branch, NHLBI Division of Intramural Research,
discussed his laboratory's research in the areas of oxidant and free radical-mediated diseases, aging, and the clinical
cardiovascular implications of stem cells.
Dr. Nabel reviewed the Institute's established translational research programs and presented new
and proposed translational approaches.
The established translational research programs discussed were the Clinical Research Networks, the
Production Assistance for Cell Therapy (PACT), and the NIH Rapid Access to Intervention Development (RAID).
New approaches discussed by Dr. Nabel were the Bench to Bassinet Program, the Pediatric Cardiac Genomics
Consortium, the Pediatric Heart Network, the Cardiovascular Development Consortium, the Cardiac Translational Research
Implementation Program (C-TRIP), the Grand Opportunities Translational Research Implementation Program (GO TRIP), the
Translational Program Project Grant (tPPG), the Phase II Clinical Trials of Novel Treatments for Lung Diseases, and the
Science Moving TowArds Research Translation and Therapy (SMARTT) program.
Finally, proposed translational approaches discussed were the Centers for Advanced Diagnostics and
Therapeutics (CADET), the NHLBI Clinical Trial Pilot Studies, and the Planning Grants for Pivotal Clinical Trials in
Hemoglobinopathies. The Council members expressed their enthusiasm for the programs.
NHLBI staff presented 8 new initiatives, 11 renewals, and 4 requests by other Institutes/Centers for
secondary support, all of which had been reviewed in October by the Board of External Experts. The Council was mostly
supportive of the initiatives presented, but made a number of specific recommendations for consideration prior to their release.
Full
minutes of Council meetings and summaries of the initiatives are available.
Upcoming NHLBI Workshops and Working Groups
No Workshops or Working Groups are scheduled for the period of January through May, 2010.
Upcoming 2010 Events
Date: January 15 - 18, 2010
Location: Arlington, TX
Date: February 2, 2010
Location: Bethesda, MD
Date: February 23 - 29, 2010
Location: San Antonio, TX
Date: March 5 - 6, 2010
Location: Washington, DC
Date: March 9 - 11, 2010
Location: Atlanta, GA
Date: March 12, 2010
Location: Needham, MA
Date: March 13 - 15, 2010
Location: To Be Announced
Date: March 19 - 21, 2010
Location: Long Island, NY
Date: April 11 - 13, 2010
Location: Boston, MA
Date: May 11 - 12, 2010
Location: Baltimore, MD
Date: May 19 - 23, 2010
Location: Bloomington, MN
Date: June 11 - 13, 2010
Location: Lake Buena Vista, FL
Date: June 18 - 20, 2010
Location: Houston, TX
Date: June 24 - 27, 2010
Location: Denver, CO
Date: June 25 - 27, 2010
Location: Garden Grove, CA
Date: July 15 - 17, 2010
Location: Halifax, Nova Scotia, Canada
Date: July 26 - 31, 2010
Location: Orlando, FL
Date: July 30 - August 1, 2010
Location: Boston, MA
Please send us your feedback, comments, and questions by using the appropriate link on the page, Contact the NHLBI.
Note to users of screen readers and other assistive technologies: please report your problems here.
Contents | Feature
Articles | In the News | Events and Meetings | Research and Resources
All Issues | FYI Index | NHLBI Express
|